+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Continuous Renal Replacement Therapy Market - Global Forecast 2026-2032- Product Image
Continuous Renal Replacement Therapy Market - Global Forecast 2026-2032- Product Image
New

Continuous Renal Replacement Therapy Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 181 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5896406
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

As demand for advanced therapies in critical care rises, the continuous renal replacement therapy market is redefining care standards and operational strategies for hospitals and manufacturers. Senior decision-makers are navigating a landscape shaped by evolving clinical requirements, technological gains, and supply chain resilience, making informed choices essential for competitive market positioning.

Market Snapshot: Continuous Renal Replacement Therapy Market

The continuous renal replacement therapy (CRRT) market is demonstrating steady expansion, with revenues growing from USD 16.75 billion in 2025 to USD 18.13 billion in 2026, and projected to reach USD 30.43 billion by 2032. This trajectory reflects rising demand for sophisticated hemodynamic support in the most critical care environments. Market momentum is reinforced by ongoing innovations in therapy modalities and device integration, alongside intelligent supply chain strategies and adaptation to regulatory shifts. The interplay of clinical need, technology evolution, and compliance strategies is propelling this growth across all major global healthcare regions.

Scope & Segmentation

  • Product Types: CRRT Systems, Accessories, and Consumables. Consumables and accessories maintain daily therapy, while system purchases drive longer-term planning, service agreements, and capital allocation decisions.
  • Clinical Modalities: Hemodiafiltration, Hemodialysis, Hemofiltration, and Ultrafiltration. Each modality influences consumable requirements, anticoagulation decisions, and integration into multidisciplinary care pathways.
  • Treatment Applications: Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD), Drug Overdose & Poisoning, Sepsis & Septic Shock. Tailored therapy protocols are essential for matching patient profiles, managing therapeutic intensity, and coordinating among specialized care teams.
  • End-User Settings: Hospitals—including Intensive Care Units and Nephrology Departments—and Ambulatory Care Centers. Operational priorities differ between inpatient and ambulatory environments, influencing uptime demands and support for clinicians and transitional care planning.
  • Regional Coverage: Americas; Europe, Middle East & Africa; Asia-Pacific. Each region adjusts procurement strategies, adoption rates, and engagement models in response to local healthcare structures and regulatory frameworks.
  • Technological Innovations: Digital monitoring, advanced cartridge designs, and updated anticoagulation protocols. These enhancements boost integration of data analytics, expand training options, and increase procedural reliability for front-line teams.

Key Takeaways for Senior Decision-Makers

  • Emerging CRRT cartridge engineering and innovative membrane materials provide more stable therapy performance and help reduce unscheduled maintenance, leading to improved lifecycle efficiency.
  • Platforms integrating devices, consumables, and analytics assist clinical decision-making, shifting operational burden from clinicians and supporting better resource allocation.
  • Tailored device strategies are necessary for different care settings, recognizing the contrast in operational goals between hospitals and ambulatory centers and the resulting impact on procurement and support models.
  • Purchasing and therapy management increasingly require input from multidisciplinary teams that span nephrology, critical care, and perfusion, creating opportunities for targeted professional education and outcome measurement.
  • Reliability of suppliers, together with responsive service networks, helps stabilize therapy access and mitigates risk during procurement cycles, especially when market conditions are volatile.
  • Regional diversification of manufacturing and service infrastructure prompts adaptive contracts and locally oriented support strategies to address infrastructure diversity across key healthcare markets.

Tariff Impact: Navigating Policy Shifts in the U.S. Market

Recent tariff actions in the United States during 2025 have encouraged both healthcare providers and CRRT manufacturers to re-evaluate sourcing and procurement processes. Resulting strategies include localization of critical component manufacturing, expansion of supplier networks, and increased logistics backup to maintain steady therapy delivery. Hospital policy is emphasizing buffer inventories, vendor-coordinated supply programs, and extended procurement agreements to counteract market disruption and guarantee continuous system availability.

Methodology & Data Sources

This report is based on structured interviews with clinicians, procurement executives, and service managers, alongside a review of current clinical research, regulatory documentation, and hospital purchasing records. Triangulation was employed to validate consistency and ensure reliable insights, while also factoring regional care protocols and regulatory standards into the analysis.

Why This Report Matters

  • Empowers healthcare executives to align operational and sourcing priorities with evolving clinical demand and emerging technology.
  • Provides manufacturers and supply partners with a framework to optimize product lines and support services across different care settings and geographies.
  • Supports risk management amid regulatory and supply chain fluctuations, ensuring continuity of patient care and operational resilience.

Conclusion

Continuous renal replacement therapy exemplifies innovation and adaptability in healthcare delivery. Organizations that prioritize strategic flexibility and cross-functional collaboration are better positioned to enhance patient care and navigate the complexities of a dynamic market environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Continuous Renal Replacement Therapy Market, by Product Type
8.1. CRRT Accessories
8.2. CRRT Consumables
8.3. CRRT Systems
9. Continuous Renal Replacement Therapy Market, by Modality
9.1. Hemodiafiltration
9.2. Hemodialysis
9.3. Hemofiltration
9.4. Ultrafiltration
10. Continuous Renal Replacement Therapy Market, by Application
10.1. Acute Kidney Injury (AKI)
10.2. Chronic Kidney Disease (CKD)
10.3. Drug Overdose & Poisoning
10.4. Sepsis & Septic Shock
11. Continuous Renal Replacement Therapy Market, by End User
11.1. Ambulatory Care Centers
11.2. Hospitals
11.2.1. Intensive Care Units
11.2.2. Nephrology Departments
12. Continuous Renal Replacement Therapy Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Continuous Renal Replacement Therapy Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Continuous Renal Replacement Therapy Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Continuous Renal Replacement Therapy Market
16. China Continuous Renal Replacement Therapy Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Anjue Medical Equipment Co., Ltd.
17.6. Asahi Kasei Medical Co., Ltd.
17.7. B. Braun Melsungen AG
17.8. Baxter International Inc.
17.9. Bellco S.r.l.
17.10. Biolight Co., Ltd.
17.11. Cytosorbents Corporation
17.12. Fresenius Medical Care AG & Co. KGaA
17.13. Full Medical Co., Ltd.
17.14. Genrui Biotech Co., Ltd.
17.15. Getinge AB
17.16. Guangzhou MeCan Medical Limited
17.17. Infomed SA
17.18. Jafron Biomedical Co., Ltd.
17.19. Kawasumi Laboratories, Inc.
17.20. Medica S.p.A.
17.21. Medites Pharma Spol s.r.o.
17.22. Medtronic plc
17.23. Mindray Medical International Limited
17.24. Nikkiso Co., Ltd.
17.25. Ningbo David Medical Device Co., Ltd.
17.26. Outset Medical, Inc.
17.27. SWS Hemodialysis Care Co., Ltd.
17.28. Terumo Corporation
17.29. Toray Medical Co., Ltd.
List of Figures
FIGURE 1. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CRRT ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CRRT ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CRRT ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CRRT CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CRRT CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CRRT CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CRRT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CRRT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CRRT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMODIAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMODIAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMODIAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMOFILTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMOFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HEMOFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ULTRAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ULTRAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ULTRAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACUTE KIDNEY INJURY (AKI), BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACUTE KIDNEY INJURY (AKI), BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY ACUTE KIDNEY INJURY (AKI), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CHRONIC KIDNEY DISEASE (CKD), BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CHRONIC KIDNEY DISEASE (CKD), BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY CHRONIC KIDNEY DISEASE (CKD), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DRUG OVERDOSE & POISONING, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DRUG OVERDOSE & POISONING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY DRUG OVERDOSE & POISONING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SEPSIS & SEPTIC SHOCK, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SEPSIS & SEPTIC SHOCK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SEPSIS & SEPTIC SHOCK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INTENSIVE CARE UNITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INTENSIVE CARE UNITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY INTENSIVE CARE UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY NEPHROLOGY DEPARTMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY NEPHROLOGY DEPARTMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY NEPHROLOGY DEPARTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 54. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 55. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 56. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 57. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 58. AMERICAS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 59. NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 61. NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 62. NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 63. NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 64. NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 65. LATIN AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. LATIN AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 67. LATIN AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 68. LATIN AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 69. LATIN AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 70. LATIN AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 77. EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 79. EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 80. EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 81. EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 82. EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 83. MIDDLE EAST CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. MIDDLE EAST CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 85. MIDDLE EAST CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 86. MIDDLE EAST CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. MIDDLE EAST CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. MIDDLE EAST CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 89. AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 91. AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 92. AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 93. AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. ASEAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. ASEAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 104. ASEAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 105. ASEAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. ASEAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. ASEAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 108. GCC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GCC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 110. GCC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 111. GCC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 112. GCC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. GCC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 114. EUROPEAN UNION CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. EUROPEAN UNION CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 116. EUROPEAN UNION CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 117. EUROPEAN UNION CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. EUROPEAN UNION CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. EUROPEAN UNION CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 120. BRICS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. BRICS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 122. BRICS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 123. BRICS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. BRICS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. BRICS CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 126. G7 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. G7 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 128. G7 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 129. G7 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. G7 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. G7 CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 132. NATO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. NATO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 134. NATO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 135. NATO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 136. NATO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. NATO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 140. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 141. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 142. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. UNITED STATES CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 145. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 146. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 147. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 148. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Continuous Renal Replacement Therapy market report include:
  • Anjue Medical Equipment Co., Ltd.
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bellco S.r.l.
  • Biolight Co., Ltd.
  • Cytosorbents Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Full Medical Co., Ltd.
  • Genrui Biotech Co., Ltd.
  • Getinge AB
  • Guangzhou MeCan Medical Limited
  • Infomed SA
  • Jafron Biomedical Co., Ltd.
  • Kawasumi Laboratories, Inc.
  • Medica S.p.A.
  • Medites Pharma Spol s.r.o.
  • Medtronic plc
  • Mindray Medical International Limited
  • Nikkiso Co., Ltd.
  • Ningbo David Medical Device Co., Ltd.
  • Outset Medical, Inc.
  • SWS Hemodialysis Care Co., Ltd.
  • Terumo Corporation
  • Toray Medical Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages181
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 18.13 Billion
Forecasted Market Value ( USD ) by 2032 $ 30.43 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Continuous Renal Replacement Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Continuous Renal Replacement Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 199 Pages
  • Global
From
Continuous Renal Replacement Therapy Equipment Market - Global Forecast 2025-2030 - Product Image

Continuous Renal Replacement Therapy Equipment Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Continuous Renal Replacement Therapy (CRRT) - Global Strategic Business Report - Product Image

Continuous Renal Replacement Therapy (CRRT) - Global Strategic Business Report

  • Report
  • 363 Pages
  • Global
From
Continuous Renal Replacement Therapy Market - Product Image

Continuous Renal Replacement Therapy Market

  • Report
  • 150 Pages
  • Global
From
Continuous Renal Replacement Therapy Machine Market Report 2025 - Product Image

Continuous Renal Replacement Therapy Machine Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Continuous Renal Replacement Therapy Market

Continuous Renal Replacement Therapy (CRRT) is a type of dialysis used to treat acute kidney injury (AKI). It is a slow, continuous process that removes waste products and excess fluid from the body. CRRT is used in critically ill patients who are unable to tolerate traditional hemodialysis. It is also used in patients with severe electrolyte imbalances, fluid overload, and acid-base disturbances. CRRT is typically used in intensive care units and can be administered for up to 24 hours a day. CRRT is a growing market, with a variety of companies offering products and services. Some of these companies include Baxter International, Fresenius Medical Care, NxStage Medical, B. Braun Melsungen AG, and Asahi Kasei Medical. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.